BYRNE ASSET MANAGEMENT LLC – Relmada Therapeutics, Inc. Transaction History
BYRNE ASSET MANAGEMENT LLC portfolio value:
$130,000
portfolio value
BYRNE ASSET MANAGEMENT LLC quarter portfolio value change:
+94.94%
quarter
Relmada Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | 64K | $37.02 | 3.5K | |
| Q2 2022 | share | Decrease | -47.57% | -3.17K shares | -114K | $18.99 | 3.5K |
| Q1 2022 | share | Increase | +15.09% | 875 shares | 49K | $26.99 | 6.67K |
| Q4 2021 | share | Increase | 0.00% | 5.8K shares | 131K | $21.71 | 5.8K |